Invention Application
- Patent Title: TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD40L ANTIBODIES
-
Application No.: US18671636Application Date: 2024-05-22
-
Publication No.: US20240392022A1Publication Date: 2024-11-28
- Inventor: Christine FARENC , Philippe TRUFFINET , Fabienne SCHUMACHER
- Applicant: Genzyme Corporation
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Priority: EP23174655.3 20230522,EP23174657.9 20230522
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00 ; A61P25/28
Abstract:
The present invention relates to treatment of relapsing forms of multiple sclerosis using an anti-human CD40L monoclonal antibody.
Information query
